State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care

If you had told me 25 years ago that we would be obsessed with weight gain, I would have thought you were crazy. Yet here I am in clinic trying to decide what to do with possible ARV medication–related weight gain.

Joseph J. Eron, Jr., MD Released: October 31, 2022

Two-drug ART continues to be a nice simplification strategy for people with HIV. Read my commentary on recent data presented at the Fall 2022 Conferences highlighting safety and tolerability of 2-drug regimens.

Darcy Wooten, MD Released: December 23, 2022